Astera Labs Files 8-K on Financials
Ticker: ALAB · Form: 8-K · Filed: Feb 10, 2025 · CIK: 1736297
| Field | Detail |
|---|---|
| Company | Astera Labs, INC. (ALAB) |
| Form Type | 8-K |
| Filed Date | Feb 10, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Astera Labs dropped an 8-K detailing financials on Feb 10, 2025.
AI Summary
Astera Labs, Inc. filed an 8-K on February 10, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 2901 Tasman Drive, Suite 205, Santa Clara, CA 95054. The report was filed under the 1934 Securities Exchange Act.
Why It Matters
This 8-K filing provides investors with crucial updates on Astera Labs' financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Astera Labs, Inc. (company) — Registrant
- February 10, 2025 (date) — Date of earliest event reported
- 2901 Tasman Drive, Suite 205, Santa Clara, CA 95054 (address) — Principal executive offices
- 1934 Act (legal_document) — SEC Act
FAQ
What specific financial information is being reported in this 8-K?
This 8-K filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K filing submitted?
The filing was submitted on February 10, 2025.
What is the official name of the company filing this report?
The exact name of the registrant is Astera Labs, Inc.
Where are Astera Labs' principal executive offices located?
Astera Labs' principal executive offices are located at 2901 Tasman Drive, Suite 205, Santa Clara, CA 95054.
Under which act is this current report being filed?
This current report is being filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 536 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-02-10 16:13:01
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ALAB Nasdaq Global Select Mar
Filing Documents
- alab-20250210.htm (8-K) — 38KB
- q424exhibit991.htm (EX-99.1) — 322KB
- asteralabs.jpg (GRAPHIC) — 14KB
- 0001736297-25-000001.txt ( ) — 531KB
- alab-20250210.xsd (EX-101.SCH) — 2KB
- alab-20250210_lab.xml (EX-101.LAB) — 23KB
- alab-20250210_pre.xml (EX-101.PRE) — 13KB
- alab-20250210_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On February 10 , 2025 , Astera Labs, Inc. (the "Company") issued a press release regarding its financial results for the quarter and year ended December 31, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in Item 2.02 of this Current Report on Form 8-K, including the accompanying Exhibit 99.1, is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Press release issued by Astera Labs, Inc. dated February 10, 2025. 104 Cover Page Interactive Data File (Cover page XBRL tags are embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 10, 2025 Astera Labs, Inc. By: /s/ Michael Tate Name: Michael Tate Title: Chief Financial Officer